Schrodinger (NASDAQ:SDGR – Get Free Report) and Talkspace (NASDAQ:TALK – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.
Analyst Ratings
This is a summary of recent ratings for Schrodinger and Talkspace, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Schrodinger | 1 | 4 | 4 | 0 | 2.33 |
| Talkspace | 0 | 8 | 1 | 0 | 2.11 |
Schrodinger currently has a consensus target price of $20.50, suggesting a potential upside of 72.12%. Talkspace has a consensus target price of $5.56, suggesting a potential upside of 7.59%. Given Schrodinger’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Schrodinger is more favorable than Talkspace.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Schrodinger | -40.37% | -29.47% | -14.69% |
| Talkspace | 3.40% | 6.89% | 5.87% |
Volatility and Risk
Schrodinger has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.
Institutional and Insider Ownership
79.1% of Schrodinger shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 21.0% of Schrodinger shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares Schrodinger and Talkspace”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Schrodinger | $255.87 million | 3.44 | -$103.26 million | ($1.42) | -8.39 |
| Talkspace | $228.87 million | 3.77 | $7.79 million | $0.05 | 103.40 |
Talkspace has lower revenue, but higher earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.
Summary
Talkspace beats Schrodinger on 8 of the 14 factors compared between the two stocks.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
About Talkspace
Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
